Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Gastrointestinal Therapeutics in Major Developed Markets to 2019The value of the IBS market amounted to an estimated $727m, and is forecast to increase at a CAGR of 14.4% between 2012 and 2019.
By: Reportstack Scope The report analyzes treatment usage patterns, market characterization, pipeline analysis and key licensing and co-development deals for the IBS, UC and CD indications in the major developed markets of the US, the UK, France, Germany, Italy, Spain, Japan and Canada. The report includes: • Disease overview and treatment usage patterns • Market size and forecast for IBS, UC and CD in major developed markets from 2012 to 2019 • Major marketed products for the indication types covered • In-depth pipeline analysis for IBS, UC and CD • Key drivers and restraints that have had and are expected to have a major impact upon the market • Key licensing and co-development agreements in the gastrointestinal therapeutics market Reasons to Buy This report will enhance your decision-making capability by enabling you to: • Align your product portfolio to the markets with high growth potential • Develop market entry and expansion strategies by identifying the potential regions and therapeutic segments that are poised for strong growth • Devise a more effectively tailored country-specific strategy through the understanding of key drivers and barriers in the gastrointestinal therapeutics market • Develop key strategic initiatives based upon an understanding of key focus areas and leading companies • Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships For more information please visit Gastrointestinal Therapeutics in Major Developed Markets to 2019 - New Drug Approvals and Promising Pipeline to Counter Declines from Patent Expiries (http://www.reportstack.com/ End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|